forked from Medical-Software-Foundation/canvas
-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
1 parent
cac6a33
commit b681a8e
Showing
1 changed file
with
15 additions
and
0 deletions.
There are no files selected for viewing
15 changes: 15 additions & 0 deletions
15
protocols/evertonmwp7_heart-failure-medication-validation_1c7f4248/README.md
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,15 @@ | ||
# Summary of Clinical Protocol for Validation of Heart Failure Medication Usage | ||
|
||
The primary goal of this protocol is to ensure the appropriate use of heart failure medications in patients who may not have an active diagnosis of heart failure. It aims to validate the necessity of these medications through a structured screening and diagnostic process. | ||
|
||
The protocol begins by identifying the initial population, which includes all patients with an active prescription for heart failure medication. From this group, a subset is considered for screening—specifically, those without an active heart failure diagnosis documented in their medical records. The protocol outlines exclusion criteria, such as patients with a history of heart failure in remission, those using the medication for off-label purposes with justification, and participants in clinical trials. | ||
|
||
The diagnostic interventions involve a comprehensive review of the patient's medical history and current medications, a clinical assessment for heart failure symptoms, and necessary diagnostic tests like echocardiograms or BNP/NT-proBNP levels. Consultation with the prescribing physician is also recommended to discuss the rationale behind the medication use. | ||
|
||
Key points to note include: | ||
- **Initial Population:** All patients with an active prescription for heart failure medication. | ||
- **Screening Subset:** Patients without an active heart failure diagnosis. | ||
- **Exclusion Criteria:** Includes patients with inactive heart failure, off-label use with justification, and clinical trial participants. | ||
- **Diagnostic Interventions:** Medical history review, clinical assessment, diagnostic tests, and physician consultation. | ||
- **Successful Screen Conditions:** Confirmation of heart failure diagnosis, alternative diagnosis or justification for medication, or medication adjustment if unjustified. | ||
- **Outcome:** Ensures appropriate medication use, with follow-up and monitoring if adjustments are made. |